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Abstract. We performed a prospective multicenter study to address the lack of data on the etiology, clinical
and demographic features of hospitalized pediatric diarrhea in Ho Chi Minh City (HCMC), Vietnam. Over 2,000
(1,419 symptomatic and 609 non-diarrheal control) children were enrolled in three hospitals over a 1-year period in
2009–2010. Aiming to detect a panel of pathogens, we identified a known diarrheal pathogen in stool samples from 1,067/
1,419 (75.2%) children with diarrhea and from 81/609 (13.3%) children without diarrhea. Rotavirus predominated in the
symptomatic children (664/1,419; 46.8%), followed by norovirus (293/1,419; 20.6%). The bacterial pathogens Salmonella,
Campylobacter, and Shigella were cumulatively isolated from 204/1,419 (14.4%) diarrheal children and exhibited extensive
antimicrobial resistance, most notably to fluoroquinolones and third-generation cephalosporins. We suggest renewed
efforts in generation and implementation of policies to control the sale and prescription of antimicrobials to curb
bacterial resistance and advise consideration of a subsidized rotavirus vaccination policy to limit the morbidity due to
diarrheal disease in Vietnam.
INTRODUCTION
Childhood diarrhea remains a serious global public health
issue, with an estimated 1.7 billion infections and 0.7 million
deaths in children under 5 years annually, most of which occur
in industrializing regions.1,2 Rotavirus (RoV) and norovirus
(NoV) are together responsible for an estimated 40% of
severe diarrhea in children in low- and middle-income coun-
tries,3 with bacterial pathogens Shigella spp., Campylobacter
spp., and Salmonella spp. commonly identified as well.4
Cryptosporidium, a protozoan, has also recently been found
to cause a significant proportion of moderate to severe diar-
rhea in children < 5 years of age in resource-poor countries.4
Diagnosis and treatment of diarrheal disease in such settings,
however, is hampered by a lack of laboratory capacity, lack of
specific clinical indicators, overuse of antimicrobial therapy,
and a resultant increase in antimicrobial resistance.5
Diarrhea is a significant cause of morbidity in children in
Ho Chi Minh City (HCMC), Vietnam,6,7 yet there is limited
data on etiology, clinical features, and prevalence of antimi-
crobial resistance among children hospitalized with diarrhea
in this setting. HCMC is a densely populated, rapidly industri-
alizing city that is home to over 8 million people in southern
Vietnam.8 Rampant antimicrobial usage in the community
has led to alarming reports of third-generation cephalosporin
and fluoroquinolone resistance among pathogenic and com-
mensal gastrointestinal bacteria.9,10 Furthermore, appropriate
treatment and prevention strategies may be hindered by a
lack of distinguishing, pathogen-specific clinical characteristics.
To address gaps in knowledge regarding hospitalized pediatric
diarrhea in HCMC, we conducted a cross-sectional hospital-
based study aiming to describe etiological and clinical features,
epidemiological characteristics, and antimicrobial susceptibility
profiles of pediatric diarrheal disease in this rapidly developing
southeast Asian city.
MATERIALS ANDMETHODS
Study sites and ethical approval. This prospective, hospital-
based study was conducted at three hospitals in HCMC: Chil-
dren’s Hospital 1 (CH1), Children’s Hospital 2 (CH2), and
the Hospital for Tropical Diseases (HTD). CH1 and CH2 are
the largest pediatric hospitals (1,500 beds each) in HCMC
while HTD is a 500-bed referral hospital in southern Vietnam.
The Scientific and Ethics Committee of CH1, CH2, HTD and
the University of Oxford Tropical Research Ethics Committee
(OxTREC No. 0109) approved this study. Written informed
consent was required from parents or legal guardians prior to
participation in the study.
Enrollment procedures and inclusion/exclusion criteria.
Children £ 60 months of age who were admitted with acute
diarrheal disease to the gastrointestinal wards of the three
hospitals from May 2009 to April 2010 were considered for
inclusion in this study as diarrheal cases. Inclusion criteria
were diarrhea as the primary reason for admission (defined
as three or more loose stools or at least one bloody loose stool
within a 24-hour period, according to the World Health Orga-
nization [WHO] guidelines),11 resident within the districts of
HCMC, and no antimicrobial treatment within 3 days prior to
study enrollment. We excluded children with a history of anti-
microbial treatment in an effort to conserve resources as we
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rarely isolate any organisms from such patients in this setting
(James Campbell, unpublished data). There were no addi-
tional exclusion criteria. The first five patients that met the
inclusion criteria were enrolled at each study site on weekdays
because of resource and staff limitations.
Children of the same age range (0–60 months) attending
CH1 or CH2 for a health check or for other gastrointestinal
issues unrelated to diarrhea, gastroenteritis, or other infectious
diseases between March and December 2010 were invited for
enrollment as hospital-based, non-diarrheal controls. Inclusion
criteria included living within the districts of HCMC, no anti-
microbial use within 3 days prior to hospital admission, and no
history of diarrhea or respiratory illness within 7 days of study
enrollment. There were no additional exclusion criteria.
Sample collection and microbiological methods. A stool
specimen was collected in a sterile container from each
enrollee as soon as possible and prior to any prescribed anti-
microbial treatment. A specimen was collected within 24 hours
of hospital admission to limit detection of nosocomial infec-
tion. Classical microbiological culturing was performed on all
collected fresh stool samples on the day of sampling to isolate
common diarrheal bacteria including Shigella spp., Salmo-
nella spp., Campylobacter spp., Yersinia spp., Plesiomonas
spp., and Aeromonas spp. as described previously.12 Specific
serotypes of Shigella spp. and Salmonella spp. were identified
by slide agglutination with antigen grouping sera and mono-
valent antisera, and Campylobacter jejuni was differentiated
from Campylobacter coli by the hippurate hydrolysis test
as previously described.12 A fresh smear of fecal specimen
was prepared in phosphate buffered saline to examine the
presence of Giardia lamblia, Entamoeba histolytica, and
Cryptosporidium cysts.12
Antimicrobial susceptibility and extended-spectrum
b-lactamase testing. The minimum inhibitory concentrations
(MICs) of bacterial isolates were determined by E-test (AB
Biodisk, Solna, Sweden) using the disc diffusion method follow-
ing the Clinical and Laboratory Standards Institute (CLSI) guide-
lines.13 Twelve antimicrobials were tested: ciprofloxacin (CIP),
ceftriaxone (CRO), ceftazidime (CAZ), amoxicillin-clavulanic
acid (AUG), erythromycin (ERY), ofloxacin (OFX), ampicillin
(AMP), trimethoprim-sulfamethoxazole (SXT), azithromycin
(AZT), chloramphenicol (CHL), gatifloxacin (GA), and nalidixic
acid (NA). The production of extended-spectrum b-lactamases
(ESBL) was detected using the double-disc synergy test: isolates
with an increase in diameter of inhibitory zone of ³ 5 mm
because of the synergy of clavulanate were considered to be
ESBL positive.14
Molecular detection of RoV and NoV. For molecular test-
ing, total viral RNA was extracted, reverse transcribed into
cDNA as previously described,15 and used to detect RoV and
NoV by reverse transcriptase polymerase chain reaction
(RT-PCR). RoV detection was performed targeting the outer
capsid genes (VP7 and VP4),16 while NoV genogroup I (GI)
and II (GII) were identified in separate PCR reactions
targeting the conserved region overlapping open reading
frame (ORF) 1–2.17 All PCR amplicons were visualized on
2% agarose gels under ultraviolet (UV) light after staining
with 3% ethidium bromide.
Molecular detection of pathogenic Escherichia coli.A total
of 360 stool samples (210 from symptomatic cases and 150
from non-diarrheal controls) that were parasite negative and
culture negative for all tested bacteria and RT-PCR negative
for RoV and NoV were randomly selected to screen for the
presence of pathogenic E. coli variants. Total nucleic acid was
extracted from these samples using an automated MagNA
Pure 96 nucleic extraction system (Roche Applied Sciences,
West Sussex, United Kingdom) according to the manufacturer’s
recommendations. Multiple PCR reactions were performed
directly on the extracted DNA to detect enterohemorrhagic
E. coli (EHEC), enteropathogenicE. coli (EPEC), enteroinvasive
E. coli (EIEC), enterotoxigenic E. coli (ETEC), and entero-
aggregative E. coli (EAEC). Multiplex real-time PCRs were
performed to detect EHEC and EPEC in one duplex reaction18
and to detect EIEC and EAEC in an additional duplex. ETEC
was detected and classified as ETEC-LT (heat labile), ETEC-ST
(heat stable), or ETEC-LT/ST using independent conventional
PCR under previously described conditions.19,20 PCR amplicons
were visualized on 2% agarose gels under UV light after staining
with 3% ethidium bromide.
Clinical and demographic data. A simple case report form
(CRF) was completed for each enrolled patient by study cli-
nicians to obtain data regarding symptoms, disease duration,
and treatment regimens as per the standard care at the study
hospitals. Study staff administered a confidential question-
naire detailing demographic, socioeconomic, and behavioral
characteristics to all enrolled individuals. Average rainfall and
temperature data for HCMC were obtained from the Vietnam
Southern Regional Hydro-Meteorological Station. The nutri-
tional status of all enrolled children was expressed as the
weight-for-age Z (WAZ) score based on WHO growth stan-
dards21; children with a WAZ score value below −2 were
considered malnourished.22
Statistical analyses. Tabulations of demographic, clinical,
and laboratory characteristics among cases and non-diarrheal
controls were performed with STATA 9.2 (StataCorp, Col-
lege Station, TX) and compared using the c2 test, Fisher’s
exact test, or Mann–WhitneyU test as appropriate. Two-sided
P values £ 0.05 were considered statistically significant.
RESULTS
Demographic characteristics. Over the study period, 1,419
diarrheal cases (referred hereafter as cases) and 609 non-diarrheal
control children (referred hereafter as non-diarrheal controls)
were enrolled; the demographic characteristics of the cases and
non-diarrheal controls are shown in Table 1. Both the cases
and non-diarrheal controls were more frequently male (64% and
53%, respectively) and had a combined median age of 12 months
(interquartile range [IQR]: 8–20 months). The non-diarrheal
controls were more likely to have a poor WAZ score than cases
(13% versus 7%; P < 0.001, c2 test). Of cases and the non-
diarrheal controls, 70% were frequently breast-fed as infants,
yet the regular use of milk formula and probiotics was more
common among the non-diarrheal controls (82%; 498/609 and
64%; 304/473, respectively) than the cases (58%; 819/1,419 and
14%; 121/861, respectively) (P < 0.001 for each comparison,
c2 test). The majority of families of the enrollees (> 80%)
resided within the urban districts of HCMC, as opposed to
the peri-urban/rural areas. In addition, cases were more likely
to report a lower income than controls. The households of
more than half of all enrolees used a government pipeline
as their major household water source; there were no signifi-
cant differences in water source between cases and the diar-
rheal controls.
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The prevalence of enteric pathogens. At least one known
enteric pathogen was identified in 75.2% (1,067/1,419) of
stool samples from the cases and in 13.3% (81/609) of stool
samples from the non-diarrheal controls (Table 2). The
majority of enrollees with an isolate-positive stool sample
(cases 91%; 970/1,067 and non-diarrheal controls 94%; 76/81)
were infected with a single pathogen from the screened panel
(see Methods). Of cases, 97 (9%) were infected with two
pathogens; including combinations of bacteria (0.4%; N = 5),
viruses (2.3%; N = 32), or virus and bacteria (4.2%; N = 60).
RoV and NoV were identified in 46.8% (664/1,419) and
20.6% (293/1,419) of all cases, respectively (Table 2). The
bacterial genera Salmonella, Shigella, and Campylobacter
were isolated from 57 (4.0%), 48 (3.4%), and 31 (2.2%) cases,
respectively. Of patients with an isolated bacterial pathogen,
67 (33%) cases had an additional pathogen (Table 2). No
Cryptosporidium isolates were identified.
In contrast to the dominance of viral infections among
cases, bacterial pathogens were identified in a greater propor-
tion than viruses among the non-diarrheal controls. Salmo-
nella was the most commonly identified bacterial pathogen of
the 609 non-diarrheal controls, isolated from a total of
39 (6.4%) stool samples (Table 2), while Campylobacter was
identified in 16 (2.6%). None of the non-diarrheal controls
were culture positive for Shigella spp. In addition, NoV and
RoV were isolated from 17/609 (2.8%) and 13/609 (2.1%),
respectively, non-diarrheal controls.
Pathogenic E. coli were detected by PCR amplification in
34% (72/210) and 55% (82/150) subset of randomly selected
stool samples from the cases and non-diarrheal controls,
respectively, in which no other pathogen was identified. As
shown in Table 3, EPEC was the most common pathogenic
E. coli variant detected, found more frequently in non-
diarrheal controls (51%; 76/150) than in diarrheal children
(19%; 39/210). However, there was significantly more atypical
EPEC detected in non-diarrheal controls than in diarrheal
cases (50% versus 18%; P < 0.001, c2 test). EAEC was the
second most common E. coli variant detected, identified in
the stools of a similar proportion of cases (9%; 18/210) and
non-diarrheal controls (11%; 17/150). EIEC and ETEC were
identified less frequently, but both were more commonly iso-
lated in children with diarrhea as shown in Table 3.
Clinical manifestations. The clinical characteristics, type of
diarrheal stool, and the presence of red and white blood cells
in stool (by microscopy) were recorded for all diarrheal cases
on admission (Table 4). Loose watery diarrhea was the most
commonly recorded stool type (79%; 1,118/1,419), which was
most prevalent among children who had a viral enteric patho-
gen in their stool (89%; 766/863). Approximately half of the
cases infected with Shigella (49%; 23/47), Campylobacter
(58%; 18/31), and Salmonella (49%; 28/57) presented with
Table 1
The demographic characteristics of diarrheal and non-diarrheal children
Characteristic
Cases
n (%)
Non-diarrheal controls
n (%)
P value§N = 1,419 N = 609
Male sex 905 (63.8) 322 (52.9) < 0.001
Median age (IQR) months 13 (8–19) 12 (8–20) 0.711
Poor WAZ* 93 (6.6) 76 (12.5) < 0.001
Breast-fed 1,017 (71.7) 465 (76.4) 0.029
Day care/nursery
school attendance
223 (15.9) 93 (15.4) 0.837
Median household
size (IQR)
6.5 (2–31) 6.4 (3–26) 0.445
Income bracket (monthly)
< $145 422 (29.7) 136 (22.3) < 0.001
$145–242 532 (37.5) 211 (34.6)
$243–483 326 (23) 168 (27.6)
$484–725 90 (6.3) 61 (10.1)
> $725 49 (3.5) 33 (5.4)
Household water source
Government pipeline 835 (59.0) 359 (59.0) 0.471
Well 501 (35.4) 223 (36.6)
Other† 81 (5.7) 27 (4.4)
Residential location‡
Rural/peri-urban 261 (18.4) 76 (12.5) 0.001
Urban 1,158 (81.6) 533 (87.5)
IQR = interquartile range; WAZ = weight-for-age Z score.
*Weight-for-age Z-score < −2.21,22
†Other household water sources include rainwater, well water, and water bought from
governmental truck dispenser.
‡Rural/peri-urban and urban districts.
§P values through c2 or Mann–Whitney U test as appropriate.
Table 2
Enteric pathogens identified in the stools of diarrheal cases and non-
diarrheal controls
Organism
Cases
n (%)
Non-diarrheal controls
n (%)
P value*N = 1,419 N = 609
Norovirus 241 (17.0) 15 (2.5) < 0.001
Rotavirus 590 (41.6) 10 (1.6) < 0.001
Campylobacter 31 (2.2) 16 (2.6) 0.544
jejuni 19 (1.3) 11 (1.8) 0.424
coli 12 (0.8) 5 (0.8) 0.955
Salmonella 57 (4.0) 34 (5.6) 0.118
Group B 35 (2.5) 12 (2.0) 0.496
Group C 8 (0.6) 0 (0.0) 0.115
Group D 4 (0.3) 1 (0.2) 1.000
spp. 9 (0.6) 21 (3.4) < 0.001
arizonae 1 (0.1) 0 (0) 1.000
Shigella 48 (3.4) 0 (0) < 0.001
flexneri 4 (0.3) 0 (0) 0.323
sonnei 44 (3.1) 0 (0) < 0.001
Other bacteria 2 (0.1) 1 (0.2) 1.000
Parasites 1 (0.1) 0 (0) 1.000
Mixed viral RoV/NoV 32 (2.3) 1 (0.2) < 0.001
Mixed viral bacterial 60 (4.2) 3 (0.5) < 0.001
Mixed bacteria 5 (0.4) 1 (0.2) 0.675
Total 1,067 (75.2) 81 (13.3) < 0.001
*P value from c2 test or Fisher’s exact test, as appropriate; boldface indicates statisti-
cal significance.
Table 3
The prevalence of pathogenic Escherichia coli variants in the stools
of diarrheal cases and non-diarrheal controls
E. coli variant
Cases
n (%)
Non-diarrheal controls
n (%)
P value*N = 210 N = 150
EPEC 39 (18.6) 76 (50.7) < 0.001
Typical 1 (0.5) 1 (0.7) 1.000
Atypical 38 (18.1) 75 (50.0) < 0.001
EHEC 2 (1.0) 1 (0.7) 1.000
EAEC 18 (8.6) 17 (11.3) 0.471
EIEC 21 (10.0) 3 (2.0) 0.002
ETEC 12 (5.7) 2 (1.3) 0.050
LT 10 (4.8) 1 (0.7) 0.029
ST 1 (0.5) 1 (0.6) 1.000
LT and ST 1 (0.5) 0 (0.0) 1.000
Mixed infections 23 (11.0) 19 (12.6)
Total 72 (34.3) 82 (54.7) < 0.001
EAEC = enteroaggregative; EHEC = enterohemorrhagic; EIEC = enteroinvasive;
EPEC = enteropathogenic; ETEC = enterotoxigenic; LT = heat labile; ST = heat stable.
*P value from c2 test or Fisher’s exact test, as appropriate; boldface indicates statisti-
cal significance.
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visible blood or mucus in their stool. The majority of all cases
had moderate (37.2–39°C) (52%; 744/1,419) or high fever
(> 39°C) (22%; 312/1,419) in addition to vomiting (78%;
1,100/1,419).
Symptomatic children with a viral pathogen in their stool
were more likely to present with dehydration and vomiting and
to have had diarrhea for a longer period prior to hospitaliza-
tion, than those with a bacterial pathogen, as shown in Table 4.
The symptomatic cases with a bacterial pathogen in their stool
were more likely to present with abdominal pain, severe fever
and to have blood cell-positive stool smears. The median age
of cases was comparable when stratified by the pathogen(s)
found in the stools, with the exception of children with a
Shigella infection (median: 31 months; IQR: 20–36 months),
who were significantly older than cases with other enteric
pathogens identified in their stool (median: 13 months; IQR:
8–19 months) (P < 0.001, Mann–Whitney U test).
Diarrheal treatment regimes. Cases with a confirmed bac-
terial infection were more likely to be prescribed an anti-
microbial on presentation (74%; 106/143) than those with a
viral infection (38%; 324/862) (P < 0.001, c2 test), where the
prescription of antimicrobials was determined by clinical pre-
sentation before etiological investigation. Approximately half
(48%; 29/60) of those with a combined bacterial/viral infec-
tion were prescribed an antimicrobial, and 60% (210/352) of
those with diarrhea of unknown origin were treated with anti-
microbials. Children with visible blood and/or mucus in their
stool were prescribed antimicrobials frequently (75%; 226/301)
as were children with high fever (68%; 214/313). The
most commonly prescribed groups of antimicrobials were
fluoroquinolones (61%; 438/714) and third-generation cepha-
losporins (22%; 160/714). Zinc and probiotics were prescribed
slightly more frequently to those who had a confirmed viral
infection (74%; 635/862 and 69%; 591/862, respectively)
than those who had a bacterial infection (66%; 95/143 and
62%; 88/143, respectively).
Spatial and temporal distribution of enteric pathogens.
Using the available location data from the diarrheal patients,
we found no association between the relative proportion of
each pathogen and population density or urban/peri-urban
locations, with RoV and NoV predominating in all districts
of the city. In addition, we found no association between the
frequency of cases caused by any of the identified pathogens
and monthly mean temperature or rainfall, with the exception
of a positive correlation between rainfall and the isolation of
Shigella spp. (Spearman’s correlation coefficient [r] = 0.592,
P = 0.043). RoV was identified more frequently in the drier
months (January–March), although the relationship was not
significant (r = −0.417, P = 0.178) (Figure 1).
Antimicrobial susceptibility. The MIC distribution of the
Campylobacter, Shigella, and Salmonella isolated from the
cases against selected antimicrobials are shown in Table 5.
The majority (³ 80%) of the Campylobacter isolates exhibited
resistance to NA and CIP, with only 8% (5/64) resistant to
ERY. A large proportion (³ 75%) of the 62 Shigella isolates
were also resistant to NA and CRO. However, the Salmonella
isolates were comparatively more susceptible to both
fluoroquinolones and third-generation cephalosporins, with
few (£ 20%) isolates displaying resistance to CRO, CIP, or
NA. Notably, the Campylobacter and Shigella isolates were
relatively susceptible to CHL, with resistance identified in
£ 2% of Campylobacter isolates, and in £ 7% of Shigella
isolates. Many (40%) of the Salmonella isolates exhibited
resistance to CHL. The majority (³ 90%) of the Campylobac-
ter and Shigella isolates demonstrated resistance to ³ 3 classes
of antimicrobials, and a high proportion of the Shigella
isolates were ESBL positive (75%; 47/62). In contrast, a
Table 4
The clinical manifestations of viral- and bacterial-associated diarrhea
Characteristic
Viral
infection
n (% or IQR)
Bacterial
infection
n (% or IQR)
Mixed viral/bacterial
infection
n (% or IQR)
P valuekN = 863 N = 143 N = 60
Bloody diarrhea 4 (0.5) 12 (8.4) 0 (0) < 0.001
Mucoid diarrhea 93 (10.8) 60 (42.0) 16 (26.7) < 0.001
Watery diarrhea 766 (86.1) 71 (49.7) 44 (73.3) < 0.001
Mild fever 480 (55.6) 73 (51.0) 33 (55.0) 0.319
Severe fever 165 (19.1) 45 (31.5) 4 (6.7) 0.001
Dehydration 92 (10.7) 4 (2.8) 6 (10.0) 0.002
Vomiting 730 (84.6) 89 (62.2) 46 (76.7) < 0.001
Cough 274 (31.7) 38 (26.6) 20 (33.3) 0.242
Abdominal pain 40 (4.6) 30 (21.0) 3 (5.0) < 0.001
Anorexia 533 (61.8) 74 (51.7) 38 (63.3) 0.027
WBC + stool 191 (22.1) 100 (69.9) 27 (45.0) < 0.001
RBC + stool 94 (10.9) 78 (54.5) 16 (26.7) < 0.001
Average daily
episodes*
4 (3–7) 5 (3–8) 5.5 (3–8.5) 0.414
Maximum daily
episodes†
10 (6–13) 10 (6–13) 10 (6–12) 0.904
Length of
illness‡
2 (2–3) 2 (1–3) 2 (1–3) < 0.001
Length of stay§ 5 (3–7) 4 (3–7) 5 (2.5–7) 0.5247
RBC = red blood cells; WBC = white blood cells.
*Average number of diarrheal episodes in a 24-hour period, as reported by the parent/
guardian.
†Maximum number of diarrheal episodes in a 24-hour period, as reported by the parent/
guardian.
‡Prior to hospitalization (days).
§Hospitalization duration (days).
kComparison of viral and bacterial infections only. Fisher’s exact, c2 or Mann–Whitney
U test as appropriate; boldface indicates statistical significance.
Figure 1. Proportion of various diarrheal etiologies among total
isolates identified per month over the course of the study period.
The proportion of isolates identified as rotavirus (medium gray),
norovirus (dark gray), Campylobacter spp. (white), Salmonella spp.
(light gray), and Shigella spp. (black) identified over each month of
the study period (May 2009–April 2010) are shown as a stacked
bar chart.
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negligible proportion of Salmonella isolates exhibited ESBL
activity (3%; 2/78).
In general, a lower proportion of pathogens isolated from
stools of the non-diarrheal controls demonstrated antimicro-
bial resistance compared with isolates from symptomatic cases.
Specifically, all Salmonella isolates from the non-diarrheal
controls were susceptible to CIP, CRO, and CAZ. Resistance
to CHL was low (2.6%; 1/39). However, many of the
Campylobacter isolates from the non-diarrheal control stool
samples were resistant to CIP (68.7%; 11/16), NA (62.5%;
10/16), and CHL (18.7%; 3/16).
DISCUSSION
This is one of the few studies addressing the causative
agents of diarrheal disease in southern Vietnam. Using the
described methods, we were able to detect at least one known
diarrheal pathogen in 75% of all diarrheal cases, which is
comparable to the findings by previous case–control studies
conducted in the north of Vietnam (67%; N = 587),23 and in
seven developing countries in Africa and Asia within The
Global Enteric Multicenter Study (GEMS) (83%; N = 9,439).4
In this study, the remaining 25% cases in which we could not
isolate a pathogen may correspond with disease caused by
alternative nontargeted pathogens, limited diagnostic sensi-
tivity, unreported pretreatment with antimicrobials, or other
causes, such as food allergy, malabsorption, or maldigestion.24
Diarrheal disease in young children in industrialized coun-
tries is generally considered to be caused by viral pathogens,
while bacterial and parasitic diarrheal agents are generally
considered more prevalent in industrializing countries.25 Here,
we identified viral pathogens more frequently than bacterial
pathogens in diarrheal cases, potentially reflecting the effect
of the recent economic transition in Vietnam on the epide-
miology of enteric pathogens in HCMC.7 Furthermore, the
large proportion of children hospitalized with RoV-induced
diarrhea in this setting predicts that uptake of RoV vaccine
would have a considerable impact on the diarrheal disease
burden in this population. In Vietnam, the current cost of
RoV immunization is prohibitive (approximately $75 for a
full course of RotaTeq [Merck, West Point, PA] or RotaRix
[GSK, Middlesex, UK]) and neither of these licensed vac-
cines are currently included in Vietnam’s Extended Program
of Immunization (EPI) schedule. We therefore suggest that
the integration of RoV vaccine into the EPI schedule should
be considered as a matter of necessity.26 An alternate way
forward for RoV vaccination in Vietnam would be through
regional mass production of a generic vaccine, such as the
live-attenuated monovalent G1P[8] (Rotavin-M1, National
Institute of Hygiene and Epidemiology, Hanoi, Vietnam)
vaccine that has recently undergone trials in Vietnam.27,28
This approach may reduce the cost of RoV immunization to
the Vietnamese health service, permitting a greater national
coverage and thus greater impact.
The variable pathogenicity of E. coli pathovars in addition
to the cost and technical difficulties in diagnostic detection of
this group have greatly hindered the understanding of disease
epidemiology and pathogenesis of this bacterial species in
childhood diarrhea, particularly in resource-limited settings.
We were able to detect the presence of five different E. coli
pathogenic variants from a random cross section of stools
from cases and non-diarrheal controls without an alternate
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identified etiology by PCR amplification. We found that atyp-
ical EPEC was the most common variant in both children with
and without diarrhea. Recent evidence from the GEMS
study suggested that atypical EPEC was not associated with
moderate-to-severe diarrhea,4 confirmed by our findings as
non-diarrheal controls were more likely to be infected with
this variant. This association with EPEC has been previously
observed.29 EPEC has also been reported to be associated
with a more persistent clinical diarrheal syndrome rather than
the acute diarrheal syndrome that was assessed here.30 We
additionally found that ETEC-LT was predominant and signif-
icantly associated with cases in comparison to non-diarrheal
controls in this study. However, findings from GEMS suggest
that ETEC-ST is a significant diarrheal pathogen and ETEC-
LT is not a significant cause of moderate-to-severe diarrhea.4
We conclude that this discrepancy reflects the differing epide-
miology of ETEC between settings, which may be related to
different routes of transmission, behavioral risk factors, and
water quality.31
The rate of pathogen detection in our non-diarrheal control
population was much lower than that identified in the GEMS
study (13% versus 72%).4 The GEMS study screened for a
wider variety of pathogens, often using more sensitive assays,
which could in part explain the difference. The exclusion of
children who had received recent antimicrobial treatment
may have biased our non-diarrheal control population as well.
Also, the controls were more likely to report higher socioeco-
nomic status indicators, and are thus likely from a different
epidemiological population than the cases, which also may
explain the low rate of pathogen detection in this group.
However, one of the more notable findings from this study
was that Salmonella spp. was detected in a similar proportion in
cases and non-diarrheal controls (6%). Campylobacter spp.,
although more common in cases (5%), was also identified in
3% non-diarrheal controls. Recent case–control studies con-
ducted in southeast Asia have found a high prevalence of
Campylobacter spp. and Salmonella spp. from healthy non-
diarrheal controls in rural Thailand and Cambodia.32,33 These
data imply that asymptomatic/transient infection with these
organisms may be substantial in these areas; further research
is warranted to determine the clinical relevance and role in
disease transmission in the community.
We found remarkable levels of antimicrobial resistance
in the pathogens isolated as part of this study; > 90% of
Campylobacter spp. and Shigella and > 50% of Salmonella
spp. isolates exhibited resistance to three or more classes
of antimicrobials. Reduced susceptibility and resistance to
broad-spectrum antimicrobials in enteric pathogens is becom-
ing increasingly reported across Asia, and our data support
the notion that resistance to multiple antimicrobial groups is
common across multiple genera of enteric pathogens.34 For
example, we found an exceptionally high prevalence of
ciprofloxacin-resistant Campylobacter, which has been
recorded in several Asian countries, including Cambodia,
India, and China.33,35,36 Antimicrobial therapy is not gener-
ally recommended to treat non-dysenteric diarrhea, although
ciprofloxacin is commonly used as a first-line antimicrobial in
the case of profuse or bloody mucoid diarrhea.37 As routine
identification of any causative agents of diarrhea is not per-
formed in hospitals in Vietnam, patients are treated following
standard Vietnamese treatment guidelines (ciprofloxacin or
ceftriaxone as first- and second-line therapies) based on clin-
ical observations, which may be insensitive in distinguishing
viral and bacterial infections. Developing affordable rapid
point-of-care diagnosis should be considered to help clinicians
choose more appropriate antimicrobial regimens for diarrheal
patients in addition to encouraging continued use of rehydra-
tion and zinc supplementation.
Ceftriaxone, a third-generation cephalosporin, is recom-
mended by the WHO as an alternative treatment of severe
infectious diarrhea and shigellosis.11,37 Yet the prevalence
of ceftriaxone resistance has increased markedly, particularly
in Shigella spp., in this location in the past decade.7,10 The
first ESBL-mediated ceftriaxone-resistant Shigella in southern
Vietnam was isolated from a pediatric diarrheal patient in
2001 at the HTD, HCMC.10 The prevalence of ceftriaxone-
resistant Shigella strains found in this study (75%) was triple
that of the 2007–2008 period in pediatric diarrheal patients in
the same hospital (23%; N = 103).7 The true prevalence of
these resistant Shigella strains circulating in the community
may be vastly underestimated because of a lack of routine
diagnosis and antimicrobial resistance surveillance in the
region. Moreover, we postulate that antimicrobial-resistant
bacteria are circulating in commensal enteric microbiota in
the community at high levels.9 This hypothesis, in addition to
the high reported rates of antimicrobial usage and resistance
in poultry in Vietnam,38 would increase the likelihood of
antimicrobial resistance gene transfer, thus increasing the
rate of emergence of multidrug-resistant strains and limiting
effective therapeutic regimes for treating patients with severe
or life-threatening bacterial infections.10 Developing solu-
tions against antimicrobial resistance is becoming a serious
global challenge as we enter the “postantibiotic era.”39,40 In
this context, we reiterate that regulating antimicrobial usage
in the community and agriculture as well as improved con-
trol of hospital prescription practices may be a critically
necessary strategy of slowing the rate of increasing antimi-
crobial resistance in this location.
Our study has some limitations. First, our non-diarrheal
control population may not adequately represent all children
without diarrhea in this community. The majority of the non-
diarrheal controls were children attending a routine clinic for
health checks, which may result in the introduction of biases.
Second, we included only the first five patients seen each day;
hence the description of seasonal patterns is limited by
the recruitment pattern. Next, the proportion of pathogen-
positive stool samples may be underestimated because our
diagnostic methods targeted a limited group of pathogens,
potentially missing other enteric pathogens such as adenovi-
rus, astrovirus, and helminths. In addition, viral etiologies
were likely identified more often due to sensitivity differences
between PCR-based diagnostics compared with culture tech-
niques used for bacterial pathogens and due to the exclusion
of patients who had received recent antimicrobial therapy.
The lack of Cryptosporidium isolates specifically, given the
high prevalence identified in the GEMS study,4 is likely due
to the poor sensitivity of microscopy.41 Finally, our study was
hospital based, thus our passive enrollment and case detection
was entirely dependent on health-care-seeking behavior.
Therefore, our study will inevitably skew results toward the
moderate-to-severe end of the disease spectrum, as the bulk
of mild infections remain undetected in the community. Not-
withstanding these limitations, we suggest that our clinical
observations, etiology, and prevalence data are informative
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and likely to be broadly representative of hospitalized diar-
rhea in this setting and other economically transitioning
regions in southeast Asia.
In conclusion, we identified a known enteric pathogen in
75% cases of hospitalized pediatric diarrhea in HCMC, with
RoV and NoV being the most frequently identified. While
bacterial pathogens were identified in only 14% cases,
alarming rates of antimicrobial resistance to recommended
first- and second-line therapies are likely to result in a grow-
ing burden of hospitalized diarrhea in young children in this
setting. We suggest renewed efforts in generation and imple-
mentation of policies to control the sale and prescription of
antimicrobials to curb bacterial resistance and advise consid-
eration of a subsidized RoV vaccination policy to limit the
morbidity due to diarrheal disease in Vietnam.
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